A Synthesis of Tamiflu by Using a Barium-Catalyzed Asymmetric Diels-Alder-Type Reaction
A Synthesis of Tamiflu by Using a Barium-Catalyzed Asymmetric Diels-Alder-Type Reaction
复制标题
DOI:
10.1002/anie.200804777
复制
发表时间:
2009-01-01
影响因子:
16.6
通讯作者:
Shibasaki, Masakatsu
中科院分区:
文献类型:
--
作者:
Yamatsugu, Kenzo;Yin, Liang;Shibasaki, Masakatsu
Influenza viruses pose a serious threat to world public health. Two of the drugs currently used to treat influenza patients are Tamiflu (1;(À)-oseltamivir phosphate)[1] and Relenza (zanamivir),[2] both of which inhibit viral neuraminidase. Currently, Tamiflu is produced and supplied by Roche using (À)-shikimic acid as the starting material.[3] The production of (À)-shikimic acid with consistent purity, however, requires a lot of time and is costly. In addition, the dependence on a single synthetic route for the supply of such an important drug is unwise. Therefore there is an urgent demand for the development of alternative practical syntheses of Tamiflu, starting from easily available starting materials.[4, 5] We report herein a new synthesis of Tamiflu which features a novel asymmetric Diels–Alder-type reaction catalyzed by a barium/F2-FujiCAPO complex.Our retrosynthetic analysis is shown in Scheme 1. The 3-pentyloxy group at C3 should be introduced at a late stage by a ring-opening reaction of an N-acetyl aziridine [4a] produced from β-alcohol 2 under Mitsunobu conditions. In our previous reports,[4b, d, e] we utilized a cyanide group as a precursor for the ester group at C1, however, its introduction and conversion into an ethoxycarbonyl group afforded only moderate yields of the desired product. Therefore, we sought